| USD ($) $ in Millions | LTM | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net revenues | $ 23,457 | $ 23,279 | $ 24,018 | $ 24,483 | ||||||||||||||
Cost of sales | 5,675 | 5,597 | 6,077 | 6,218 | ||||||||||||||
Excise taxes on products | 3,013 | 3,140 | 3,574 | 3,981 | ||||||||||||||
Gross profit | 14,769 | 14,542 | 14,367 | 14,284 | ||||||||||||||
Marketing, administration and research costs | 2,513 | 2,507 | 2,737 | 2,737 | ||||||||||||||
Reduction of PMI tax-related receivable | - | - | - | - | ||||||||||||||
Changes to Mondelēz and PMI tax-related receivables/payables | - | - | - | - | ||||||||||||||
Asset impairment and exit costs, net of cash paid | - | 978 | 389 | - | ||||||||||||||
Impairment of goodwill | 285 | 1,158 | - | - | ||||||||||||||
Gain on sale of corporate headquarters building | - | - | - | - | ||||||||||||||
Recoveries from airline industry exposure | - | - | - | - | ||||||||||||||
Amortization of intangibles | - | - | - | - | ||||||||||||||
Operating income | 10,973 | 9,899 | 11,241 | 11,547 | ||||||||||||||
Interest and other debt expense, net | (1,095) | (1,079) | (1,037) | (989) | ||||||||||||||
Loss on early extinguishment of debt | - | - | - | 0 | ||||||||||||||
Net periodic benefit income, excluding service cost | (34) | (59) | (102) | (127) | ||||||||||||||
(Income) losses from investments in equity securities | 464 | 510 | 652 | 243 | ||||||||||||||
Gain on the sale of IQOS System commercialization rights | - | 0 | 2,700 | - | ||||||||||||||
Earnings from equity investments | - | - | - | - | ||||||||||||||
Impairment of JUUL equity securities | - | - | - | - | ||||||||||||||
Loss on Cronos-related financial instruments | - | - | - | 0 | ||||||||||||||
Loss on ABI/SABMiller business combination | - | - | - | - | ||||||||||||||
Other income, net | - | - | - | - | ||||||||||||||
Earnings before income taxes | 10,376 | 9,389 | 13,658 | 10,928 | ||||||||||||||
Provision for income taxes | 2,403 | 2,442 | 2,394 | 2,798 | ||||||||||||||
Earnings from continuing operations | - | - | - | - | ||||||||||||||
Earnings from discontinued operations, net of income taxes | - | - | - | - | ||||||||||||||
Net earnings | - | - | - | - | ||||||||||||||
Net losses attributable to noncontrolling interests | - | - | - | - | ||||||||||||||
Amounts attributable to Altria Group, Inc. stockholders: | ||||||||||||||||||
Earnings from continuing operations | - | - | - | - | ||||||||||||||
Net earnings | 7,973 | 6,947 | 11,264 | 8,130 | ||||||||||||||
Earnings from discontinued operations | - | - | - | - | ||||||||||||||
Net earnings attributable to Altria Group, Inc. | - | - | - | - | ||||||||||||||
Per share data: | ||||||||||||||||||
Basic and diluted earnings per share attributable to Altria Group, Inc. (usd per share) | - | - | - | - | ||||||||||||||
Basic earnings per share: | ||||||||||||||||||
Continuing operations | - | - | - | - | ||||||||||||||
Discontinued operations | - | - | - | - | ||||||||||||||
Basic earnings per share attributable to Altria (in usd per share) | 4.75 | 4.12 | 6.54 | 4.57 | ||||||||||||||
Diluted earnings per share: | ||||||||||||||||||
Continuing operations | - | - | - | - | ||||||||||||||
Discontinued operations | - | - | - | - | ||||||||||||||
Diluted earnings per share attributable to Altria (in usd per share) | $ 4.75 | $ 4.12 | $ 6.54 | $ 4.57 |